Clinical Trials Browser

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT00922974 2025-04-29

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

Phase 2/3 Completed

399 enrolled 29 charts

Neoplasm Metastasis, Pain

NCT03295565 2022-04-15

OSTRICh

Phase 2/3 Completed

100 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT03031444 2021-02-01

PARECEC

Phase 2/3 Completed

135 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00212615 2020-11-06

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Phase 2/3 Completed

116 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03936205 2019-05-14

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Phase 2/3 Completed

18 enrolled

Neoplasm Metastasis, Pain, Intractable

NCT02711007 2018-04-23

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Phase 2/3 Completed

37 enrolled

Sarcoma

Neoplasm Metastasis, Osteosarcoma

NCT01572727 2017-03-09

BELLE-4

Phase 2/3 Completed

416 enrolled 11 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT00389155 2015-12-07

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Phase 2/3 Completed

34 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT00561990 2015-10-15

Nimotuzumab in Adults With Pancreatic Cancer

Phase 2/3 Completed

188 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT00401323 2011-01-20

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 2/3 Completed

568 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local

NCT00290953 2008-12-23

SESAME

Phase 2/3 Completed

432 enrolled

Thoracic

Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT00035334 2006-02-14

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Phase 2/3 Completed

150 enrolled

GastrointestinalGenitourinaryPlasma cell

Amyloidosis, Arthritis, Rheumatoid, Gastrointestinal Diseases, Kidney Diseases, Neoplasm Metastasis, Nephrotic Syndrome, Familial Mediterranean Fever

NCT00055562 2005-06-24

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Phase 2/3 Completed

274 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

Clinical Trials

TRIPLET

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

OSTRICh

PARECEC

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

BELLE-4

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Nimotuzumab in Adults With Pancreatic Cancer

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

SESAME

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma